For Professional Clients and, in Switzerland, for Qualified Investors only. In Israel for Sophisticated Investors only.
English
  • English
  • French
  • German
  • Spanish
en
  • en
  • fr
  • de
  • es
Filter by theme
Filter by date
Filter by boutique
Filter by theme
Filter by date
Filter by boutique
No posts matching your criteria
Clear theme
Clear all
No posts matching your criteria
Clear date
Clear all
No posts matching your criteria
Clear boutique
Clear all
For Professional Clients and, in Switzerland, for Qualified Investors only. In Israel for Sophisticated Investors only.
English
  • English
  • French
  • German
  • Spanish
en
  • en
  • fr
  • de
  • es
© 2020. BNY Mellon Investment Management EMEA Limited. All rights reserved.
IDEAS AND KNOWLEDGE TO INSPIRE YOUR INVESTMENTS THINKING
6 August 2020

Why telemedicine matters in today’s markets

With the continued spread of COVID-19, many are asking themselves how we can be better prepared for such a catastrophic event in the future. There are myriad technologies that are currently underutilized which could see accelerated adoption in a world rapidly shaped by this global pandemic. On the front lines of an emerging outbreak, telemedicine is spurring a new way to care for patients.

 

As COVID-19 upends global supply chains, consumer confidence and the stock market, we believe there are connected health companies that will ultimately become stronger because of it. Telemedicine has been in existence for several years, but is coming to the forefront as a feasible solution as social distancing is enforced and as healthcare systems become stretched. This public crisis could bring a slew of new patients to adopt the valuable experience of a virtual examination. We think patient behaviour is set to change and the telemedicine industry will penetrate deeper into the market for routine doctor office visits.

 

While telemedicine has been a critical alternative thus far, only a small percentage of the addressable population is utilizing it. Of the patients who have tried it, 84% said they were able to completely resolve their medical concerns in the visit1. In our ever-connected world, consumers are discovering they don’t have to wait in a doctor’s office to receive care.

 

Matthew Jenkin, senior research analyst healthcare and Kyle McDonough, research associate, Mellon.

 

1 Telehealth: Best Consumer Healthcare Experience You’ve Never Tried, Says J.D. Power Study. J.D. Power 2019 U.S. Telehealth Satisfaction Study. Accessed at: https://www.jdpower.com/business/press-releases/2019-us-telehealth-satisfaction-study Press Release. 

Please note the content on this website is for Investment Professionals only and should be shared responsibly. No other persons should rely on the information contained within this website.

 

Investment Managers are appointed by BNY Mellon Investment Management EMEA Limited (BNYMIM EMEA), BNY Mellon Fund Management (Luxembourg) S.A. (BNY MFML) or affiliated fund operating companies to undertake portfolio management activities in relation to contracts for products and services entered into by clients with BNYMIM EMEA, BNY MFML or the BNY Mellon funds.

Subscribe to updates